Patent details

EP3291814 Title: AN ANTI-CANCER AGENT 1-((4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-6-METHOXYQUINOLIN-7-YLOXY)METHYL) CYCLOPROPANAMINE, ITS CRYSTALLINE FORM AND ITS SALTS

Basic Information

Publication number:
EP3291814
PCT Application Number:
US2016030483
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167899160
PCT Publication Number:
WO2016179123
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AN ANTI-CANCER AGENT 1-((4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-6-METHOXYQUINOLIN-7-YLOXY)METHYL) CYCLOPROPANAMINE, ITS CRYSTALLINE FORM AND ITS SALTS
French Title of Invention:
UN AGENT ANTICANCÉREUX, 1-((4-(4-FLUORO-2-MÉTHYL-1H-INDOL-5-YLOXY)-6-MÉTHOXYQUINOLINE-7-YLOXY)MÉTHYL) CYCLOPROPANAMINE, SA FORME CRISTALLINE ET SES SELS
German Title of Invention:
EIN MITTELS GEGEN KREBS, (1-(4-(4-FLUOR-2-METHYL-1H-INDOL-5-YLOXY)-6-METHOXYCHINOLIN-7-YLOXY)METHYL)CYCLOPROPANAMIN, DESSEN KRISTALLINE FORM UND DESSEN SALZE
SPC Number:

Dates

Filing date:
03/05/2016
Grant date:
10/07/2024
EP Publication Date:
14/03/2018
PCT Publication Date:
10/11/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/07/2024
EP B1 Publication Date:
10/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/05/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/07/2024
 
 

Name:
Advenchen Pharmaceuticals, LLC
Address:
887 Patriot Drive, Ste A, Moorpark, CA 93021, United States (US)

Name:
Chen, Guoqing Paul
Address:
887 Patriot Drive, Ste A, Moorpark, CA 93021, United States (US)

Inventor

1

Name:
YAN, Changren
Address:
United States (US)

2

Name:
CHEN, Guoqing, Paul
Address:
United States (US)

Priority

1

Priority Number:
201562156734 P
Priority Date:
04/05/2015
Priority Country:
United States (US)

2

Priority Number:
201562205272 P
Priority Date:
14/08/2015
Priority Country:
United States (US)

3

Priority Number:
201615143630
Priority Date:
02/05/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61K 45/06; A61K 31/337; A61K 31/4709; A61K 31/4745; A61K 31/555; C07D 401/12; C07K 16/22; C07C 55/10; C07C 57/145; A61P 9/10; A61P 27/02; A61P 35/00; A61P 35/02; A61K 33/243;

Publication

European Patent Bulletin

Issue number:
202428
Publication date:
10/07/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages